Pemphigus Herpetiformis with Only Positive Anti-Envoplakin Antibodies: A Case Report

Cristina Sousa, M. Campos, J. D. Lopes, O. Baptista, A. Oliveira
{"title":"Pemphigus Herpetiformis with Only Positive Anti-Envoplakin Antibodies: A Case Report","authors":"Cristina Sousa, M. Campos, J. D. Lopes, O. Baptista, A. Oliveira","doi":"10.35248/1745-7580.19.15.170","DOIUrl":null,"url":null,"abstract":"Pemphigus herpetiformis, first described in 1975, is a rare subtype of autoimmune bullous disease that associates clinical features of dermatitis herpetiformis with immunological features of pemphigus. We present a 48-years-old female patient, with pruritic lesions located mainly in the upper limbs with 6 years of evolution. Physical examination revealed erythematous papules, some excoriated and vesicles of translucent content distributed on her arms, trunk and neck. Histological examination of a skin biopsy revealed the presence of sub epidermal vesicles associated with necrosis of the epidermis and perivascular lymphocytic infiltrate in the papillary and reticular dermis. The immunological study was positive for antibodies to intercellular IgG and anti-envoplakin antibodies. Anti-desmoglein 1 and 3 antibodies were negative. Considering these results, the clinical hypothesis of pemphigus herpetiformis was admitted. The positivity of the anti-envoplaquine antibody is often associated with paraneoplastic pemphigus, so a cancer screening was performed which was negative. Prednisolone and dapsone was introduced with resolution of lesions. To our knowledge this is the first clinical case of pemphigus herpetiformis with positive anti-envoplakin antibodies. This rare and often overlooked entity has a good prognosis, although there are cases reports with progression to pemphigus vulgaris or pemphigus foliaceus.","PeriodicalId":73347,"journal":{"name":"Immunome research","volume":"96 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunome research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/1745-7580.19.15.170","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Pemphigus herpetiformis, first described in 1975, is a rare subtype of autoimmune bullous disease that associates clinical features of dermatitis herpetiformis with immunological features of pemphigus. We present a 48-years-old female patient, with pruritic lesions located mainly in the upper limbs with 6 years of evolution. Physical examination revealed erythematous papules, some excoriated and vesicles of translucent content distributed on her arms, trunk and neck. Histological examination of a skin biopsy revealed the presence of sub epidermal vesicles associated with necrosis of the epidermis and perivascular lymphocytic infiltrate in the papillary and reticular dermis. The immunological study was positive for antibodies to intercellular IgG and anti-envoplakin antibodies. Anti-desmoglein 1 and 3 antibodies were negative. Considering these results, the clinical hypothesis of pemphigus herpetiformis was admitted. The positivity of the anti-envoplaquine antibody is often associated with paraneoplastic pemphigus, so a cancer screening was performed which was negative. Prednisolone and dapsone was introduced with resolution of lesions. To our knowledge this is the first clinical case of pemphigus herpetiformis with positive anti-envoplakin antibodies. This rare and often overlooked entity has a good prognosis, although there are cases reports with progression to pemphigus vulgaris or pemphigus foliaceus.
疱疹型天疱疮抗包膜蛋白抗体阳性1例报告
疱疹样天疱疮首次报道于1975年,是一种罕见的自身免疫性大疱性疾病亚型,它将疱疹样皮炎的临床特征与天疱疮的免疫学特征联系起来。我们报告一位48岁的女性患者,搔痒性病变主要位于上肢,6年的发展。查体发现:患者手臂、躯干及颈部有红斑丘疹,部分有剥破,有透明物囊泡分布。皮肤活检的组织学检查显示表皮下小泡与表皮坏死有关,乳头状和网状真皮中有血管周围淋巴细胞浸润。免疫学检查细胞间IgG抗体和抗包膜蛋白抗体阳性。抗粘粒蛋白1、3抗体均为阴性。考虑到这些结果,承认疱疹样天疱疮的临床假设。抗envoplaquine抗体的阳性通常与副肿瘤天疱疮有关,因此进行了癌症筛查,结果为阴性。病变消退后,应用强的松龙和氨苯砜治疗。据我们所知,这是第一例疱疹样天疱疮抗包膜蛋白抗体阳性的临床病例。这种罕见的,经常被忽视的实体有良好的预后,虽然有进展为寻常性天疱疮或叶状天疱疮的病例报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信